Performant Healthcare Investors Alert: Kahn Swick & Foti Investigating Proposed Sale

Kahn Swick & Foti, LLC is investigating the proposed sale of Performant Healthcare, Inc. to Machinify, with shareholders receiving $7.75 in cash per share. KSF is seeking to determine if this consideration and the process are adequate or if the consideration undervalues the company. If you have concerns, you can contact KSF Managing Partner Lewis S. Kahn toll-free at 855-768-1857 or visit ksfcounsel.com.

New York & New Orleans, September 12, 2025 — Kahn Swick & Foti, LLC (KSF), led by former Attorney General of Louisiana Charles C. Foti, Jr., has initiated an investigation into the proposed sale of Performant Healthcare, Inc. (NASDAQ: PHLT) to Machinify. The investigation aims to determine whether the consideration and process leading to the proposed transaction are adequate or if the consideration undervalues the company.

Under the terms of the proposed transaction, shareholders of Performant will receive $7.75 in cash for each share they own. KSF is examining whether this consideration is fair and if the process followed to reach this valuation is appropriate. The law firm is particularly interested in assessing whether the proposed sale undervalues Performant Healthcare.

Shareholders who believe the transaction undervalues the company are encouraged to contact KSF Managing Partner Lewis S. Kahn toll-free at 855-768-1857 or visit the firm's website at [ksfcounsel.com/cases/nasdaqgs-phlt/](https://www.ksfcounsel.com/cases/nasdaqgs-phlt/) to discuss their legal rights without any obligation or cost.

Kahn Swick & Foti, LLC is known for its expertise in securities law and has represented investors in various high-profile cases. The firm's partners, including former Attorney General Foti, are renowned for their commitment to investor rights and corporate accountability.